Therapeutic Targets Database
BIDD Pharmainformatics Databases


TTD Drug ID: DAP000396

Drug Information
Synonyms52232-67-4; Forteo; Teriparatide (genetical recombination); Teriparatide (genetical recombination) (JAN); Teriparatide (USAN/INN); Forteo (TN); D06078; TERIPARATIDE    
Trade NameForteo    
CompanyEli Lilly and Company    
IndicationOsteogenesis imperfectaApproved    [1]

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
Therapeutic ClassBone Density Conservation Agents    
CAS NumberCAS 52232-67-4
PubChem Compound IDCID 16129682.    
PubChem Substance IDSID 181193.    
SuperDrug ATC IDH05AA02;    
SuperDrug CAS ID052232674;    
TargetParathyroid hormone/parathyroid hormone-related peptide receptorBinder[2][3][4]
Ref 1Natural products as sources of new drugs over the last 25 years. J Nat Prod. 2007 Mar;70(3):461-77. Epub 2007 Feb 20. To Reference
Ref 2Parathyroid hormone, its fragments and their analogs for the treatment of osteoporosis. Treat Endocrinol. 2002;1(3):175-90. To Reference
Ref 3The N-terminal fragment of human parathyroid hormone receptor 1 constitutes a hormone binding domain and reveals a distinct disulfide pattern. Biochemistry. 2000 Aug 1;39(30):8878-87. To Reference
Ref 4A constitutively active mutant PTH-PTHrP receptor in Jansen-type metaphyseal chondrodysplasia. Science. 1995 Apr 7;268(5207):98-100. To Reference


Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.

Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore

All rights reserved.

Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543